Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension
VANESSA
1 other identifier
observational
50
1 country
1
Brief Summary
This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension. Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
January 11, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2025
CompletedJanuary 16, 2025
January 1, 2025
1 year
January 11, 2025
January 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Diastolic Dysfunction
Diastolic Dysfunction found in transthoracal echocardiography assessment
Up to 1 weeks
Study Arms (2)
Patient with LVDD
Investigators will assess MVP score by reviewing patient 12-lead ECG. Furthermore, the MVP score will be analyzed with echocardiography result.
Patient without LVDD
Investigators will assess MVP score by reviewing patient 12-lead ECG. Furthermore, the MVP score will be analyzed with echocardiography result.
Interventions
Transthoracal echocardiography for diastolic function assessment
Eligibility Criteria
Patient with essential hypertension who came to out hospital
You may qualify if:
- Essential hypertension
You may not qualify if:
- Secondary or resistant hypertension
- LVEF\<55%
- Congenital heart disease
- Infiltrative cardiomyopathy
- Coronary artery disease
- Chronic kidney disease
- Valvular heart disease
- Bundle branch block
- Arrhythmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Kariadi Central General Hospital
Semarang, Central of Java, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; Former of Head of Department of Cardiovascular Medicine Faculty of Medicine Universitas Diponegoro
Study Record Dates
First Submitted
January 11, 2025
First Posted
January 16, 2025
Study Start
January 1, 2024
Primary Completion
December 31, 2024
Study Completion
March 15, 2025
Last Updated
January 16, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share